LIVN LivaNova PLC

$55.29

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 11/21/2025

About LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.

Website: https://www.livanova.com

Sector
LIFE SCIENCES
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1639691
Address
20 EASTBOURNE TERRACE, LONDON, GB
Valuation
Market Cap
$1.93B
P/E Ratio
30.67
PEG Ratio
1.51
Price to Book
1.47
Performance
EPS
$1.16
Dividend Yield
Profit Margin
5.05%
ROE
4.87%
Technicals
50D MA
$40.87
200D MA
$47.78
52W High
$64.47
52W Low
$32.48
Fundamentals
Shares Outstanding
54M
Target Price
$59.90
Beta
0.90

LIVN EPS Estimates vs Actual

Estimated
Actual

LIVN News & Sentiment

Nov 11, 2025 • Benzinga SOMEWHAT-BULLISH
Cardiac Arrest Treatment Market Set for Remarkable Growth Driven by Advanced Emergency Care and Rising Cardiac Cases: Verified Market Research®
Lewes, Delaware, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Cardiac Arrest Treatment Market Size projected to grow at a CAGR of 4.50% from 2024 to 2031, according to a new report published by Verified Market Research®.
Oct 28, 2025 • Benzinga BULLISH
Implantable Heart Pacemaker Market is expected to generate a revenue of USD 6.19 Billion by 2031, Globally, at 3.30% CAGR: Verified Market Research®
Lewes, Delaware, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- The Global Implantable Heart Pacemaker Market Size is projected to grow at a CAGR of 3.30% from 2024 to 2031, according to a new report published by Verified Market Research®.
Oct 02, 2025 • Zacks Commentary BULLISH
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
Sep 18, 2025 • Benzinga SOMEWHAT-BULLISH
Neuromodulation Market is expected to generate a revenue of USD 9.32 Billion by 2032, Globally, at 9.27% CAGR: Verified Market Research®
Lewes, Delaware, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- The Global Neuromodulation Market Size is projected to grow at a CAGR of 9.27% from 2026 to 2032, according to a new report published by Verified Market Research®.
Aug 06, 2025 • Benzinga BULLISH
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday - Astera Labs ( NASDAQ:ALAB ) , Arista Networks ( NYSE:ANET )
U.S. stocks were mostly higher, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Shopify Inc. SHOP rose sharply during Wednesday's session after the company reported better-than-expected quarterly sales.
Jul 21, 2025 • Benzinga SOMEWHAT-BULLISH
Sleep Apnea Devices Market is expected to generate a revenue of USD 14.59 Billion by 2031, Globally, at 10.42 % CAGR: Verified Market Research®
Lewes, Delaware, July 21, 2025 ( GLOBE NEWSWIRE ) -- The Global Sleep Apnea Devices Market Size is projected to grow at a CAGR of 10.42% from 2024 to 2031, according to a new report published by Verified Market Research®.
Sentiment Snapshot

Average Sentiment Score:

0.105
50 articles with scored sentiment

Overall Sentiment:

Neutral

LIVN Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
0.18 Surprise
  • Reported EPS: $1.05
  • Estimate: $0.87
  • Whisper:
  • Surprise %: 21.0%
May 07, 2025
Mar 31, 2025 (Pre market)
0.39 Surprise
  • Reported EPS: $0.88
  • Estimate: $0.49
  • Whisper:
  • Surprise %: 79.6%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.81
  • Estimate: $0.80
  • Whisper:
  • Surprise %: 1.2%
Oct 30, 2024
Sep 30, 2024 (Pre market)
0.18 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.72
  • Whisper:
  • Surprise %: 25.0%
Jul 31, 2024
Jun 30, 2024 (Pre market)
0.15 Surprise
  • Reported EPS: $0.93
  • Estimate: $0.78
  • Whisper:
  • Surprise %: 19.2%
May 01, 2024
Mar 31, 2024 (Pre market)
0.24 Surprise
  • Reported EPS: $0.73
  • Estimate: $0.49
  • Whisper:
  • Surprise %: 49.0%
Feb 21, 2024
Dec 31, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $0.87
  • Estimate: $0.77
  • Whisper:
  • Surprise %: 13.0%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $0.73
  • Estimate: $0.64
  • Whisper:
  • Surprise %: 14.1%
Jul 26, 2023
Jun 30, 2023 (Pre market)
0.24 Surprise
  • Reported EPS: $0.78
  • Estimate: $0.54
  • Whisper:
  • Surprise %: 44.4%

Financials